Home » Topics » Regulatory

Regulatory
RSS

Theravance and Astellas obtain FDA approval of Vibativ

Sep. 16, 2009

Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis

Sep. 1, 2009

FDA approves Embeda for moderate to severe chronic pain

Aug. 17, 2009

Saphris approved by FDA for schizophrenia and bipolar I disorder

Aug. 17, 2009

Invega approved for the treatment of schizoaffective disorder

Aug. 6, 2009

Invega Sustenna approved for acute and maintenance schizophrenia treatment

Aug. 5, 2009

FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes

Aug. 4, 2009

Wyeth's Prevenar 13 pneumococcal vaccine approved in Chile

July 16, 2009

FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease

July 1, 2009

FDA approves Allergan's Ozurdex for macular edema following retinal vein occlusion

June 22, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...